CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04371978
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:09.797761+00:00
Published At: 2021-06-02T00:00:00+00:00
Record Updated At: 2021-06-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["COVID 19", "Coronavirus", "Diabetes Mellitus, Type 2", "Diabetes Mellitus", "Glucose Metabolism Disorders", "Metabolic Disease", "Endocrine System Diseases", "Dipeptidyl-Peptidase IV Inhibitors", "Linagliptin", "Severe Acute Respiratory Syndrome Coronavirus 2", "Sars-CoV2", "Hypoglycemic Agents", "Respiratory Tract Diseases", "Incretins", "Hormones"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-06-02"
protocolSection.identificationModule.nctId: "NCT04371978"
protocolSection.identificationModule.officialTitle: "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.